Clinical Trial Update: A Study of TRK-950 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry reports an ongoing Phase 1/2 study of TRK-950 in patients with advanced solid tumors, including melanoma, that is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Solid Tumor

Drugs mentioned

• TRK-950

Snippet

Sponsor: Toray Industries, Inc | Conditions: Solid Tumor, Melanoma | Phase 1, Phase 2 | Status: RECRUITING